The Defense Advanced Research Projects Agency will hold a virtual proposers day on Aug. 27 to discuss the broad agency announcement for the Assessing Immune Memory Program.
DARPA officials will talk about the development initiative for a tool planned to examine the immune memory responses of military service members to vaccination, a notice on SAM.gov said Friday.
The AIM program looks for proposals that would combine biomolecular profiling approaches with computational methods to help predict how long a vaccine’s protection would last against communicable diseases and other biological threats.
The initiative is aimed at measuring immune cell responses to vaccine perturbations, creating a testable mechanism for immune memory development and forecasting the immune system’s response based on early host response, among other goals.
DARPA’s Biological Technologies Office will accept requests to attend the virtual event until Aug. 24.
The BAA comes amid what the agency described as ignorance toward immune memory and the inability to measure cellular factors affecting long-lasting immune protection.